US$ 22.16
the benefits of glp 1 drugs beyond obesity Unstoppable Rise GLP-1 Agonists: Revolutionising Diabetes and Treatment Beyond the anti-obesity benefits of
Description
What are health insurers covering

Several employees have sued health insurance companies for excluding coverage of GLP-1 medications prescribed solely to treat obesity, arguing that such obesity exclusion constitutes disability discrimination under the ACA

GLP-1 agonists work on brain reward pathways and appetite regulation centers, potentially reducing the hedonic or reward-driven aspects of eating

However, there are some rare but serious risks, including pancreatitis and gallbladder issues

These products have dosing limitations that must be considered and may limit their use in some patients with T2D
